To evaluate the efficacy of yapana basti(medicated enema) and nasya (nasal drops)along with shirobasti followed by kauncha paka in the management of kampavata with special reference to parkinson’s disease (pd)
Phase 2
Completed
- Conditions
- Health Condition 1: G20- Parkinsons disease
- Registration Number
- CTRI/2022/06/043053
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
. Patients between 40-70 years of age.
2. Patients with clinical signs and symptoms of Kampavata/ PD.
3. Patients of either sex irrespective of their occupation, religion and socio-economic
status.
4. Patients of Kampavata/PD who are fit for Shirobasti , Basti and Nasya.
5. Patients willing to participate for interventional study.
Exclusion Criteria
. Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem,
Uncontrolled Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
2. Patients unfit for Shirobasti , Basti and Nasya.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of changes will be assessed on the basis of UPDRS <br/ ><br>(Unified Parkinson’s disease Rating Scale) (modified) before and after the treatment.Timepoint: Assessment will be done at <br/ ><br>Day 0, Day 16, Day 31 and after follow-up of 15 days
- Secondary Outcome Measures
Name Time Method Assessment of changes in following specific signs and symptoms of Kampavata <br/ ><br>1 kampa <br/ ><br>2 chestasang <br/ ><br>3 stambha <br/ ><br>4 gati vikriti <br/ ><br>5 avanamna <br/ ><br>6 vak vikriti <br/ ><br>(PD). <br/ ><br>Timepoint: at the base line day and After completion of trial.